Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B

Background: There is no consensus for the best treatment of complex cutaneous leishmaniasis (CL). We aimed to describe a cohort of CL, focusing on liposomal amphotericin B (L-AmB) treatment outcome. Methods: We performed a retrospective study in Vall d’Hebron University Hospital (Barcelona, Spain)....

Full description

Bibliographic Details
Published in:	Pathogens
Main Authors:	Maria Ubals, Pau Bosch-Nicolau, Adrián Sánchez-Montalvá, Fernando Salvador, Gloria Aparicio-Español, Elena Sulleiro, Aroa Silgado, Antoni Soriano-Arandes, Maria Espiau, Berta Ferrer, Diana Pou, Begoña Treviño, Israel Molina, Vicente García-Patos
Format:	Article
Language:	English
Published:	MDPI AG 2021-09-01
Subjects:	complex cutaneous leishmaniasis cutaneous leishmaniasis liposomal amphotericin B leishmania systemic therapy
Online Access:	https://www.mdpi.com/2076-0817/10/10/1253

Similar Items

Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes
by: Guilherme S. Ramos, et al.
Published: (2022-05-01)

Leishmaniasis cutánea y anfotericina B liposomal: Reporte de caso
by: Juan Diego Vélez L, et al.

Intravenous Liposomal Amphotericin B for Complicated Pediatric Cutaneous Leishmaniasis: A Case Series
by: Moshe Shmueli, et al.
Published: (2025-08-01)

Cutaneous leishmaniasis in a renal transplant patient: Diagnostic challenges in a non-endemic setting
by: Zishan Nasir, et al.
Published: (2025-01-01)

Comprehensive analysis of Amphotericin B: innovations and clinical applications in tropical dermatoses and beyond – A narrative review
by: Aditya K. Bubna, et al.
Published: (2025-04-01)

Ursolic Acid Potentializes Conventional Therapy in Experimental Leishmaniasis
by: Jéssica Adriana Jesus, et al.
Published: (2020-10-01)

Genomic characterization of Leishmania (V.) braziliensis associated with antimony therapeutic failure and variable in vitro tolerance to amphotericin B
by: Laura Natalia Gonzalez-Garcia, et al.
Published: (2025-04-01)

Disseminated leishmaniasis: clinical, pathogenic, and therapeutic aspects
by: Gustavo Uzêda Machado, et al.
Published: (2019-02-01)

Activity of Amphotericin B-Loaded Chitosan Nanoparticles against Experimental Cutaneous Leishmaniasis
by: Alaa Riezk, et al.
Published: (2020-09-01)

Sporotrichoid leishmaniasis
by: Luan Zorzin, et al.
Published: (2024-07-01)

Meglumine antimoniate was associated with a higher cure rate than liposomal amphotericin B in the treatment of American tegumentary leishmaniasis: A retrospective cohort study from a Leishmania braziliensis-endemic area
by: Daniel Holanda Barroso, et al.
Published: (2022-09-01)

Urban Cutaneous Leishmaniasis in North of Tehran
by: Aref Saleh Zadeh, et al.
Published: (1997-03-01)

PECULIARITIES OF MANIFESTATION OF THE SKIN FORM OF LEISHMANIASIS OF MAXILLOFACIAL LOCALIZATION
by: M.G. Skikevych, et al.
Published: (2020-06-01)

American cutaneous leishmaniasis in a northeast Brazilian city: clinical and epidemiological features
by: Cícero Roberto Pinheiro Grangeiro Júnior, et al.

High Selectivity of 8-Hydroxyquinoline on <i>Leishmania (Leishmania)</i> and <i>Leishmania (Viannia)</i> Species Correlates with a Potent Therapeutic Activity In Vivo
by: Sarah Kymberly Santos de Lima, et al.
Published: (2023-05-01)

Efficacy and safety of a single dose pentamidine (7mg/kg) for patients with cutaneous leishmaniasis caused by L. guyanensis: a pilot study
by: Ellen Priscilla Nunes Gadelha, et al.
Published: (2015-12-01)

Cutaneous leishmaniasis: a case report
by: BMM Kayastha, et al.
Published: (2012-01-01)

Cutaneous leishmaniasis: a case report
by: BMM Kayastha, et al.
Published: (2012-01-01)

Efficacy of adjunctive topical liposomal clarithromycin on systemic Glucantime in Old World cutaneous leishmaniasis: a pilot clinical study
by: Atousa Hakamifard, et al.
Published: (2023-11-01)

Co-delivery of amphotericin B and pentamidine loaded niosomal gel for the treatment of Cutaneous leishmaniasis
by: Adnan Anjum, et al.
Published: (2023-12-01)

Epidemiology of Cutaneous Leishmaniasis in Qom Province, Iran, during 2003-2009
by: A Saghafipour, et al.
Published: (2012-04-01)

Epidemiology of Cutaneous Leishmaniasis in Qom Province, Iran, during 2003-2009
by: Saghafipour A., et al.
Published: (2012-04-01)

Local therapies in cutaneous leishmaniasis: a review study
by: Sadegh Vahabi-Amlashi, et al.
Published: (2020-03-01)

Field Efficacy of Topical Nano-Liposomal Amphotericin B (Sina Ampholeish®) Alone or in Combination with Glucantime® and Cryotherapy on Human Cutaneous Leishmaniasis
by: Zahra Alizadeh, et al.
Published: (2023-11-01)

A Review of the Progress in the Development of Leishmaniasis Vaccines
by: Narges Khaghanzadeh, et al.
Published: (2024-07-01)

Multiple sclerosis among patients with previous diagnosis of leishmaniasis
by: Mehrdad Farrokhi, et al.
Published: (2015-04-01)

Epidemiological Study of Cutaneous Leishmaniasis in Kermanshah Province, 2011-2019
by: Ameneh Asadi, et al.
Published: (2022-09-01)

Outbreak of cutaneous leishmaniasis in the Rio Doce Valley, Minas Gerais, Brazil
by: Marco Victor Hermeto, et al.
Published: (1994-12-01)

Effectiveness of Sambucus ebulus Leaf Extract in Treatment of Cutaneous Leishmaniasis: A Double Blind Clinical Trial
by: Omid Mozafari, et al.
Published: (2020-02-01)

Occurrence of two autochthonous cases of American cutaneous leishmaniasis in the neighborhood of Caju, city of Rio de Janeiro, Brazil
by: Fred Bernardes Filho, et al.
Published: (2014-09-01)

Molecular diagnosis and therapy for cutaneous leishmaniasis of a returned traveler from Mexico
by: Pei-Hsuan Tsai, et al.
Published: (2021-12-01)

American tegumentary leishmaniasis: epidemiological and molecular characterization of prevalent Leishmania species in the State of Tocantins, Brazil, 2011-2015
by: Carina Scolari Gosch, et al.
Published: (2017-12-01)

Clinico-immunological spectrum of American tegumentary leishmaniasis and leprosy coinfection: A case series in Southeastern Brazil
by: Sebastian Vernal, et al.
Published: (2019-04-01)

Brief communication: Vitamin D serum levels in American tegumentary leishmaniasis from an endemic area in Northeast Brazil
by: Lorena Pinheiro Figueiredo, et al.
Published: (2023-01-01)

Rare and first case report of a diffused cutaneous leishmaniasis from Uttar Pradesh state, India
by: Hasmatullah Khan, et al.
Published: (2025-01-01)

Cutaneous leishmaniasis in cats (Felis domesticus) caused by Leishmania (Leishmania) venezuelensis
by: Rafael Bonfante Garrido, et al.
Published: (2010-07-01)

Cross-protective immunity to Leishmania amazonensis is mediated by CD4+ and CD8+-epitopes of Leishmania donovani Nucleoside Hydrolase terminal domains
by: Dirlei eNico, et al.
Published: (2014-05-01)

In Vitro Efficacy and Toxicity Assessment of an Amphotericin B Gel for the Treatment of Cutaneous Leishmaniasis
by: Lilian Sosa, et al.
Published: (2025-03-01)

Determination of Immunoglobulin's levels in cutaneous Leishmainasis patients
by: Nuha S. Al-Bayatii, et al.
Published: (2023-02-01)

An assessment of interobserver agreement on lesion size, morphology and clinical phenotype in cutaneous leishmaniasis caused by Leishmania aethiopica in Ethiopia [version 2; peer review: 2 approved]
by: Stephen L. Walker, et al.
Published: (2025-05-01)